Collaborations
Partnering with pharmaceuticals and other biotechnology companies is part of Recoly’s strategy in pursuing the commercialization of its technologies.
Bayer Healthcare LLc.
Recoly licensed to Bayer Healthcare LLC. the use of the NecLip liposome with recombinant FVIII for the development and commercialization of a long-acting recombinant FVIII consisting of Recolyís NecLip liposome and Bayerís Koganate FS. The combined product BAY-794980 is in phase II clinical trials (see clinical trial info).
